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Eighty-four patients with insulin-dependent diabetes mellitus had stud-
ies of renal function and quantitative renal morphometry including
mesangial volume fraction (Vvmegiom), index of arteriolar hyalinosis,
percentage of globally sclerosed glomeruli (%GS), and interstitial
volume fraction for total renal cortex (Vv1,). There was significant
correlation among these four parameters, and all four structural param-
eters correlated with glomerular filtration rate and the log of urinary
albumin excretion. Stepwise multiple regression analysis showed that
Vvmes,giom and Vv1, were additive, suggesting that they are partiallyindependent. Arteriolar hyalinosis and %GS did not improve the
correlations further. We hypothesize that VVmigom, arteriolar
hyalinosis, and %GS represent multiple but probably interrelated
pathologic mechanisms leading to the functional disturbances of dia-
betic nephropathy. Longitudinal studies of patients with diabetes and
studies of patients with diseases producing interstitial expansion in the
absence of glomerular disease may help clarify the independent role of
interstitial expansion in the kidney disease of diabetes mellitus.
Studies of glomerular structure have shown striking correla-
tions with renal function in insulin-dependent diabetes mellitus
(IDDM) and have provided convincing evidence that mesangial
expansion is a critical lesion in this disease [1, 21. The accumu-
lation of mesangial matrix material and, to a lesser extent,
expansion of the cellular compartment of the mesangium com-
promises contiguous glomerular capillaries resulting in a loss of
filtration surface [3—5]. This loss of glomerular capillary surface
has been proposed as an explanation for the loss of glomerular
filtration rate (GFR) and other clinical manifestations of dia-
betic nephropathy [1, 4, 5].
Other important renal structural changes occur in IDDM. The
percent of glomeruli with global sclerosis also correlates with
GFR and proteinuria, and probably represents another mecha-
nism for loss of filtration surface in IDDM [6]. It has been
hypothesized that global glomerulosclerosis may result from
two distinct processes. First, mesangial expansion may ulti-
mately result in capillary closure. Second, the severity of
arteriolar hyalinosis correlates with the percent of globally
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sclerosed glomeruli, suggesting a role for vascular lesions and
ischemia in their pathogenesis [6].
The degree of expansion of the interstitium has been said to
be the best correlate of function and prognosis in many renal
diseases. Three studies have addressed the renal interstitium in
IDDM. Bader et al studied 103 biopsies from middle-aged
diabetic patients and found that quantitative measures of the
proportion of the renal cortex composed of interstitium corre-
lated with the serum creatinine [7]. Mesangial expansion was
assessed only with a semiquantitative sclerosis score; serum
creatinine and the prevalence of nephrotic syndrome both
increased with increasing sclerosis score. While interstitial
disease was not directly compared to proteinuria, the severity
of interstitial expansion also increased with increasing sclerosis
score, suggesting a relationship between interstitial expansion,
mesangial expansion, and proteinuria. FrØkjr Thomsen et al
examined autopsy specimens from 34 long-term IDDM patients
and found that interstitial and mesangial lesions, quantitated on
light microscopy, both correlated with serum creatinine and the
presence or absence of severe clinical nephropathy [8]. Mesan-
gial lesions correlated better than interstitial abnormalities in
both cases. Our previous work reported biopsies from 45 IDDM
patients [2]. Mesangial volume fraction, the proportion of the
glomerular tuft composed of mesangial cells and matrix, was
measured using standard electron microscopic techniques, but
the interstitium was assessed using a semiquantitative scoring
system. While mesangial and interstitial measurements both
correlated with creatinine clearance and urinary albumin excre-
tion (UAE), the lesions correlated strongly with each other (r =
0.80; P < 0.0005), and no independent effect of either lesion on
renal function could be demonstrated.
While all of these studies have shown relationships between
interstitial lesions and various measures of renal function, none
have simultaneously quantitated glomerular lesions, interstitial
expansion, and renal function [2, 7, 8]. Furthermore, each study
demonstrated or suggested a correlation between mesangial and
interstitial expansion. We undertook the present study to ex-
plore the relationship between interstitial and glomerular le-
sions in IDDM, especially mesangial expansion, arteriolar
hyalinosis, and global glomeruloscierosis. We also examined
the relationship of these parameters to renal function in this
disease.
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Methods
Patient population
One hundred and seventy-four IDDM patients [120(69%)
female] with native kidneys and serum creatinine values < 177
xM (2.0 mg!dl) have undergone evaluation for possible pancreas
transplantation or improved metabolic control in the Clinical
Research Center (CRC) at the University of Minnesota Hospi-
tals and Clinics. These studies were approved by the Commit-
tee for the Use of Human Subjects in Research at the Univer-
sity of Minnesota, and were performed only after informed
consent was obtained. While these patients may not be repre-
sentative of the diabetic population as a whole, this group does
include a broad spectrum of renal findings of IDDM, from
normal renal function and structure to clinical nephropathy with
advanced structural changes. The patient selection methods
should not affect the structural-functional relationships de-
scribed here. All but 27 patients had at least 2, and usually 3, 24
hour urine collections for creatinine clearance (Car) and urinary
albumin excretion (UAE). The 27 patients with less than two
urine collections were excluded from the present study. Serum
and urine creatinine was measured according to an automated
kinetic method that used the Jaffé reaction [9]. We have
previously demonstrated a nearly perfect correlation between
multiple Cr collected under supervision in our CRC and inulin
clearance in diabetic patients whose Cr was > 40 mllmin/1 .73
m2 of body surface area (r = 0.92; P < 0.001) [4]. Normal Cr
for our laboratory is 90 to 120 mi/mm/I .73 m2. Low Cr was
therefore < 90 mi/mm/I .73 m2. UAE was quantitated with
nephelometry [10]. Normal UAE is 22 mg/24 hr or less ( 15
ig/min). Of these 147 patients, 85 patients had overt nephrop-
athy (UAE > 200 mg124 hr), 17 patients had "microalbumin-
uria" (UAE 45 to 200 mg/24 hr), and 33 patients had normal
UAE. We selected 45 mg124 hr as the lower limit of microalbu-
minuria because long-term study has confirmed its predictive
value [11]. The remaining 12 patients had UAE in the range of 23
to 44 mg/24 hr. Although this degree of albumin excretion is
greater than normal, most studies have not found UAE in this
range to be predictive of nephropathy risk [12—15], nor is it
indicative of renal structural changes [16].
From this population of 147 patients 51 patients were ex-
cluded because they lacked adequate tissue for electron micro-
scopic morphometry and quantitation of the interstitium by
light microscopy. The remaining 96 patients were divided into
six groups based on renal function studies. Twenty-five patients
had normal UAE or UAE in the range of 23 to 44 mg!24 hr and
normal or elevated Ce,. (NUAE/NCCr), 10 patients had normal
UAE or UAE in the range of 23 to 44 mg!24 hr and low Cr
(NUAEILCCr), 9 patients had microalbuminuria and normal or
elevated Cr (Micro!NCcr), 8 patients had microalbuminuria
and low Cr (Micro/LCcr), 17 patients had overt proteinuria and
normal or elevated Cr (Overt/NCcr), and 17 patients had overt
proteinuria and low C1 (Overt/LCcr). In the latter group a
lower limit of 55 mi/minI! .73 m2 was used for Car. This was the
lowest clearance seen in the patients without overt proteinuria.
No patient was excluded for a Ce,. below this limit. Data were
analyzed with and without the patients with UAE 23 to 44 mg!24
hr. Since their inclusion changed no clinical or structural
characteristic of any of the groups, they are included in the
NUAEINCCr (10 patients) and NUAEILCCr (2 patients) groups.
Twenty-four of these 96 patients were included in our previous
study [2].
In addition to the studies described above, all patients had an
evaluation of their renal anatomy, usually an intravenous py-
elogram. Renal area index was determined from measurements
made on intravenous pyelograms and body weight and height
[17]. Renal area index was equal to the sum of left kidney width
x left kidney length and right kidney width x right kidney
length expressed per 1.73 m2 of body surface area. We have
previously reported a normal value of 180 25 cm2!! .73 m2 for
this parameter [17]. Glucose control was assessed with hemo-
globin Al determination by HPLC (normal range: 5.4 to 7.4%)
[18]. Each patient had 10 to 15 blood pressure measurements
over several days. Hypertension was defined using the Criteria
of the Joint National Committee on the Detection, Evaluation,
and Treatment of High Blood Pressure [19]. Patients taking
medication specifically to lower blood pressure were consid-
ered hypertensive regardless of blood pressure measurement.
Tissue preparation
At the time of percutaneous renal biopsy the tissue was
examined under a dissecting microscope to insure that an
adequate number of glomeruli were present. Part of the tissue
was immersed in Zenker's fixative and processed in paraffin for
light microscopy. Serial sections were stained with periodic-
acid Schiff (PAS) and numbered so that separate populations of
glomeruli could be studied.
One mm cubes of renal cortex were processed for electron
microscopy as previously described [21. Once embedded, 1 m
sections were cut and stained with toluidine blue so that the
centermost nonscierosed glomerulus that was at least one
tubular diameter from the tissue edge could be identified for
further study. Totally obliterated giomeruli with no open capil-
lary loops were omitted from sampling. Multiple electron mi-
crographs were taken from each glomerulus, and a calibration
grid was photographed with each one to determine final magni-
fication. All tissues for light and electron microscopy were
coded and read masked as described below.
Light microscopy
Mean glomerular volume was estimated using the method
described by Hirose et a! [20]. Average glomerular profile area
was determined via point counting on at least 15 glomerular
profiles, and mean volume then calculated. PAS stained sec-
tions at least 100 m apart were used in order to reduce the
possibility of studying more than one profile from any glomer-
ulus. The percentage of globally sclerosed glomeruli (%GS) was
estimated from the same profiles; 33 21(15 to 76) profiles
were examined from each patient. We have previously demon-
strated  9% as the normal range of this parameter in nondia-
betic persons in the age range of the patients studied here [6].
Index of arteriolar hyalinosis was determined as a semiquan-
titative estimate of the replacement of arteriolar smooth muscle
by waxy, homogeneous PAS-positive material using the follow-
ing scoring system: incomplete replacement of a few of the
vessel profiles was 0.5, incomplete replacement of half the
profiles was 1.0, incomplete replacement of most vessel profiles
was 1,5, complete replacement of a few profiles was 2.0,
complete replacement of half of the profiles was 2.5, complete
replacement of most vessel profiles was 3.0, and complete
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replacement of all vessel profiles was 3.5 [2]. Scores of at least
2.0 have been associated with elevated percent globally scle-
rosed glomeruli [6].
Interstitial volume fraction (Vvjnt,coex), the proportion of the
renal cortex made up of interstitial tissue, was determined in the
following manner. A grid was superimposed on a high power
(400x) field of cortex stained with PAS. The grid divided each
field into two halves, and each half had six evenly spaced
points, 64 m apart at this magnification. Each half of the field
was first scored as qualitatively normal or abnormal, and the
points falling on interstitium and on all tissue were recorded for
each half. Interstitium was defined as that portion of the cortex
not composed of glomeruli, tubules, arteries, arterioles, or
veins with a diameter at least the size of a tubule. The adventitia
of large vessels was also excluded from the interstitium. Cap-
illaries and smaller veins were considered part of the intersti-
tium. Fields of medulla were not included. Abnormal fields
were defined as those containing globally scierosed glomeruli,
atrophic tubules, tubules with extreme thickening or wrinkling
of the basement membrane, an inflammatory infiltrate, or
sectioning artifact. No systematic attempt was made to evaluate
the frequency of any type of abnormality; however, sectioning
artifacts and cellular infiltrates seemed uncommon, and most
abnormal fields contained globally sclerosed glomeruli or atro-
phic tubules. Only normal fields were used to generate a volume
fraction for interstitium per normal areas of the cortex (Vv1),
only abnormal fields were used to generate a volume fraction
for interstitium per abnormal areas of the cortex (VVt,A), and
all fields were used to generate the interstitial volume fraction
per total cortex (VvIfl/T). The percentage of abnormal fields
were determined to estimate the proportion of abnormal cortex
for each biopsy. One observer (PHL) measured all the patients
in the study. Thirty patients were studied on two occasions, and
the correlation of duplicate readings for was r = 0.87 (P
= 0.0001) when  20 half-fields were scored. In addition to the
diabetic groups described above, interstitial quantification was
performed on 18 age- and sex-matched nondiabetic kidney
donors to develop normal values for VVjnticoex (0.15 0.02).
Normal VV,/.r and normal were considered to be 0.19
(mean + SD).
Electron microscopy
At least two, and usually three, glomeruli were studied from
each patient. Mesangial volume fraction (VVmesigjom), the pro-
portion of the glomerular capillary tuft made up of mesangial
cells and matrix, was estimated by point counting as previously
described [21. Normal Vvmes,giom was considered to be 0.22
[21].
Harmonic mean thickness of the glomerular basement mem-
brane (GBM) was estimated using the orthoganol intercept
method [22]. The thickness of the GBM was measured at the
points of interception of a linear probe and the endothelial-
GBM interface.
Filtration surface density of the peripheral capillary filtration
surface was estimated by counting the intersections of a linear
probe with the peripheral capillary surface [4]. Filtration sur-
face density was determined by dividing twice the number of
intersections by the total length of the line used. Filtration
surface per glomerulus was determined by multiplying the
filtration surface density by the mean glomerular volume. Total
surface per kidney was estimated by multiplying the filtration
surface per glomerulus by the number of glomeruli without
global sclerosis per kidney. The latter was determined by
assuming that each kidney had 1,000,000 glomeruli. This was
multiplied by I — %GS to determine the number of functioning,
open glomeruli. Thus, total surface = filtration surface per
glomerulus x [1,000,000(1 — %GS)].
Statistics
All values are reported as mean standard deviation. One
way analysis of variance (ANOVA) was performed to identify
parameters which differed among the groups. Chi square anal-
ysis was used for categorical data. Where differences were
shown to exist by ANOVA, relationships between pairs of
groups were further tested with the Scheffé F-test. Vvjnt,co,ex
values for the diabetic groups were compared to the nondiabetic
group with Dunnett's i-test. The interrelationships of various
structural and functional parameters were tested using linear
regression analysis or chi square analysis. Where more than one
factor showed significant correlation, stepwise multiple regres-
sion analysis was performed. A P value <0.05 was considered
significant.
Results
Results were similar whether patients with UAE of 23 to 44
mg/24 hr were included or excluded. Results reported here
include these patients in the NUAE/NCcT and NUAE/LCCr
groups as described above. The six groups were similar for age,
duration of diabetes, gender, and metabolic control (Table 1).
Ccr was similar among the groups with normal Cr and among
the groups with low Car. UAE was similar among groups within
the same UAE category. The prevalence of hypertension in-
creased with increasing renal dysfunction (P < 0.01 by chi
square analysis). MAP in patients not receiving medication
specifically to lower blood pressure was greater in the groups
with elevated UAE compared to the two groups with normal
UAE (P < 0.001 by ANOVA). Renal area index differed among
the groups, and tended to be lower in groups with low Cr
(Table 1). Renal area index correlated with Cr (r = 0.39, P <
0.01) as we have previously demonstrated [17]. Renal area
index inversely correlated with %GS (r = 0.35, P < 0.01), but
did not correlate with any other structural parameter.
There was no difference among the groups for mean glomer-
ular volume, filtration surface per glomerulus, and total surface,
although there was a tendency for filtration surface per glomer-
ulus and total surface to decrease with reduced renal function
(Table 2). GBM width did vary among the groups (P < 0.01 by
ANOVA). The groups with overt proteinuria were greater than
the group with normal renal function (Table 2).
Vvmes,giom also varied among the groups (P < 0.001 by
ANOVA; Table 2). This parameter was greater in the groups
with proteinuria when compared with the group with normal
function. It was also greater in patients in the Overt/LCcr group
when compared with the NUAE/LCCr, MicrofNC, and Micro!
LCr groups.
Index of arteriolar hyalinosis varied among the groups as did
%GS (P < 0.001 by ANOVA for both parameters; Table 2). The
groups with most advanced renal dysfunction had greater
arteriolar hyalinosis scores than the group with normal function
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Table 1. Clinical and renal function data for six groups of insulin-dependent diabetic patients
NUAE Microalbuminuria Overt proteinuria
NCr LCr NCr LCcr NCcr LCcr
Number of patients 35 10 9 8 17 17
Age years 31 8 33 8 29 7 32 5 31 9 30 5
Duration of IDDM years 18 8 22 9 19 9 22 5 17 6 21 5
Gender 24F:11M 1OF:OM 7F:2M 7F:1M 12F:5M 9F:8M
HbA1 % 10.3 2.0 10.2 1.6 11.4 2.1 10.6 2.3 10.8 1.6 10.2 1.7
Ccrml/minhl.73 m 122 20 77 10 123 29 84 2 114 25 73 8
UAE mg/24 hr
Hypertension ()y)b
15 9
4
16 12
1
92 38
4
115 50
3
849 970
7
1109 816
11
MAP mm Hg (N)" 88 8 (33) 83 6 (9) 90 6 (5) 98 7 (5) 93 5 (10) 94 4 (6)
Renal area index cm2Il.73 m2 (N)d 205 21(21) 179 21(6) 220 16 (6) 197 31(6) 220 33 (12) 191 32 (13)
a Mean standard deviation
bP < 0.01 by chi square analysis
"P< 0.001 byANOVAd P < 0.05 by ANOVA
Abbreviations are: IDDM, insulin-dependent diabetes meffitus; Ccr, creatinine clearance; UAE, urinary albumin excretion; N, number; MAP,
mean arterial pressure in those patients not receiving antihypertensive medication; NUAE, normal urinary albumin excretion; NCr, normal or
elevated creatinine clearance; and LCr, low creatinine clearance.
Table 2. Renal structure data for six groups of insulin-dependent diabetic patients
NUAE Mieroalbuminuria Overt proteinuria
NC LCcrNCc LCcr NC LCr
G8M width nm"
VVmeOm"
Mean glomerular volume (x 106 pm3)
Filtration surface per glomerulus
(X iO pm2)
%GS"
Total surface (x lO nn2)
Index of arteriolar hyalinosis"
Vv,,,,A"
Abnormal fields %"
556 l27
0.22 0.07
1.63 0.47
157 50
3±6
15 5
1.0 0.7
0.24 0.08
48 28
592 179
0.28 0.06
1.42 0.53
142 72
13±15
12 7
1.8 0.6
0.25 0.09
68 16
653 172
0.28 0.08
1.77 0.32
132 21
9±11
12 1
1.8 0.7
0.23 0.05
48 21
597 99
0.28 0.09
1.60 0.39
124 25
15±1310 3
1.9 0.9
0.29 0.0564 26
692 138
0.34 0.12
2.08 0.66
154 67
8±814 7
2.0 1.0
0.31 0.0550 28
714 109
0.41 0.10
2.22 0.60
113 49
24±20
10 5
2.0 0.9
0.33 0.05
72 19
a Mean standard deviationb P< 0.01 by ANOVA
C P < 0.001 by ANOVA
Abbreviations are: GBM, glomerular basement membrane thickness; VVmesj&om, mesangial volume fraction; VU, mean glomerular volume;
%GS, percentage of globally sclerosed glomeruli; Vv,,,.A, interstitial volume fraction for abnormal renal cortex; NUAE, normal urinary albumin
excretion; NCr, normal or elevated creatinine clearance; and LCcr, low creatinine clearance. The following comparisons had P< 0.05 with Scheffé
F-test: GBM, NUAE/NCCr vs. both OvertINc and Overt/LCcr, VVmesigiom, NUAEINCCr vs. both Overt/NCcr and OvertlLCcr, and NUAE/LCCT,
MicrofNCcr and Micro/LCcr vs. OvertlLCcr; %CIS, NUAEINCCr and Overt/NCr. vs. Overt/LCcr; Index of arteriolar Hyalinosis, NUAEINCCr vs.
Micro/LCcr, OvertfNCcr and Overt/LCcr; VV,,IA, NUAE/NCCr and MicrolNCcr vs. Overt/LCcr; Abnormal fields, none.
(Table 2). The Overt/LCcr group had higher %GS than both the
normal function group and the Overt/NCcr group (Table 2).
was greater in all the diabetic groups than in the
nondiabetic control group (P < 0.001 by ANOVA, Fig. 1).
Differences were seen among the IDDM groups as well (P <
0.001 by ANOVA for the 6 IDDM groups). Vvfl,N was greater
in most diabetic groups than in the nondiabetic group (P < 0.001
by ANOVA, Fig. 2). Only the NUAE/LCCr group did not have
VvflIN greater than the nondiabetic group. The OvertlLCcr
group had greater Vv,N than the NUAE/NCCr group; other-
wise Vvm was similar among the IDDM groups. The percent-
age of abnormal fields did not vary significantly among the
diabetic groups by Scheffd test (Table 2). The differences in
Vv could thus be accounted for by differences in VvIfl/A (P
<0.001 by ANOVA, Table 2).
Neither VVm or VvflflIT con-elated with patient age. Both
correlated weakly with duration of IDDM (Vv,N, r = 0.29,
<0.05; Vv,,,T, r = 0.25, P < 0.05). VVIflIJA did not correlate
with duration (r = 0.10).
As renal dysfunction increased among the groups, the pro-
portion of patients with abnormalities in at least two of four
structural parameters (VVmesigiom, Vv,,T, index of arteriolar
hyalinosis, and %GS) increased (NUAE/NCCr 15 of 35, NUAE/
LCr 7 of 10, Micro/NCcr 8 of 9, Micro/LC 7 of 8, Overt/NCcr
14 of 17, and OVert/LCcr 17 of 17; P < 0.01 by chi square
analysis).
Selected structural parameters were examined for interrela-
tionships. VVmeSISIOm con-elated with VVi,rr (r = 0.38, P <
0.01), index of arteriolar hyalinosis (r 0.42, P < 0.001), and
%GS (r = 0.42, P < 0.001). also correlated with %GS (r
= 0.54, P < 0.001) and index of arteriolar hyalinosis (r = 0.25,
P < 0.05). Index of arteriolar hyalinosis > 2 was associated
with elevated %GS on chi square analysis (P < 0.01) as we have
previously shown and with elevated Vv,.,. (P < 0.01) [61.
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NUAE Microalbumin Overt
NCCr LCCr NCCr LCCr NCCr LCCr
Fig. 1. Interstitial volume fraction for total renal cortex (Vv,,/T) in six
groups of insulin-dependent diabetic patients. The range of values
(mean 2 SD) seen in age- and sex-matched nondiabetic kidney donors
is shaded. P < 0.001 by ANOVA for six IDDM groups with nondiabetic
group. All IDDM groups were greater than the nondiabetic group by
Dunnett's t-test (P < 0.05 for NUAE/LCCr vs. nondiabetic group; P <
0.01 for other comparisons). ANOVA remained significant when the
nondiabetic group was excluded (P < 0.001). Among the diabetic
groups, the following comparisons had P < 0.05 by Scheff F-test:
NUAE/NCCr, NUAE/LCCr, and Micro/NCcr vs. Overt/LCcr. Abbrevi-
ations are: NUAE, normal urinary albumin excretion; Microalbumin,
microalbuminuria; Overt, overt proteinuria; NCcr, normal or elevated
creatinine clearance; LCr, low creatinine clearance.
0.00
NUAE Microalbumin Overt
NCCr LCCr NCCr LCCr NCCr LCCr
Fig. 2. Interstitial volume fraction for qualitatively normal areas of the
renal cortex (Vv,,N) in six groups of insulin-dependent diabetic pa-
tients. The range of values (mean 2 SD) seen in age- and sex-matched
nondiabetic kidney donors is shaded. P < 0.001 by ANOVA for the six
IDDM groups with the nondiabetic group. All IDDM groups except
LCCr/NUAE (P > 0.05) were greater than the nondiabetic group by
Dunnett's t-test (P < 0.05 for each comparison). P < 0.05 by ANOVA
for the six diabetic groups. Only NUAE/NCCr vs. Overt/LCcr was
significant by Scheff test. Abbreviations are: NUAE, normal urinary
albumin excretion; Microalbumin, microalbuminuria; Overt, overt pro-
teinuria; NCr, normal or elevated creatinine clearance; LCr, low
creatinine clearance.
Structural-functional relationships were examined by linear
regression analysis. Ce,. correlated with '1"mes/gtom (r = —0.41,
P < 0.001), Vv,,,,.5 (r =
—0.49, P < 0.001), index of arteriolar
hyalinosis (r = —0.26, P < 0.05), and %GS (r = —0.41, P <
0.01). VVmesigiom and Vv,,,,.r were additive on stepwise multiple
regression analysis (r = 0.55 P < 0.001); arteriolar hyalinosis
and %GS did not contribute further to structural correlation
with CCr.
UAE, not normally distributed, was logarhythmically trans-
formed, and it correlated with the same structural parameters
(vs. VVmesigiom r = 0.57, vs. r = 0.52, vs. index of
artenolar hyalinosis r = 0.43, and vs. %GS r = 0.40; P < 0.001
for each correlation). Vvmes,giom and Vv1 were additive on
stepwise multiple regression analysis (r =0.66, P <0.001), and
artenolar hyalinosis increased the correlation further (r = 0.68,
P < 0.001). Since MAP may influence UAE independent of
underlying renal structure, MAP was examined in all 96 patients
and found to correlate with logUE (r = 0.47, P < 0.001). MAP
was additive with Vvmes,giom, and index of arteriolar
hyalinosis on multiple regression analysis (r =0.72, P < 0.001).
Discussion
We analyzed 96 IDDM patients by quantitative renal func-
tional and structural studies. We have focused on interrelation-
ships of cortical interstitial volume fraction with Vymesigiom,
index of arteriolar hyalinosis, and %GS since these lesions have
previously been demonstrated to correlate with renal function
in IDDM [2, 6]. Our measurement of is similar to the
interstitial quantification done in the studies of Bader and
FrØkjr Thomsen [7, 8]. Since interstitial expansion accompa-
nies global glomerular sclerosis or tubular atrophy of any cause,
we also analyzed interstitial expansion in cortical regions not
associated with these lesions. We fully recognize that the
boundaries between normal and abnormal areas of renal cortex
are not precisely definable and that, as a consequence, this
categorization does not follow strict stereologic principles and
cannot be considered as an exact quantitative measure. How-
ever, as the results indicate, this definition of normal and
abnormal areas can aid in the understanding of interstitial
alterations in IDDM. Moreover, data are also presented for the
total interstitium, based on methods which require no subjec-
tive subclassification of renal cortical zones.
The structural-functional relationships described here largely
confirm our earlier observations [2]. Both VVmesigiom and
Vvjntrr correlated with GFR and UAE with little or no strength-
ening of these correlations by measures of arteriolar hyalinosis
or glomerular sclerosis. Although Vvmes,giom and Vv1,.1- are
directly correlated, multiple regression analyses have suggested
that these were somewhat independently related to glomerular
function. The relationship between Vv- and %GS was stron-
ger than that between VVIflt,T and Vvmes,giom. This was expected
since the differences in Vvjnt,.r between patient groups were
largely determined by abnormal areas of the cortex, many of
which were associated with globally sclerosed glomeruli. Since
%GS is known to correlate with index of arteriolar hyalinosis,
the interrelationship of Vvm and arteriolar hyalinosis we
demonstrated was anticipated [61.
The observation that Vv is increased in patients with
longstanding IDDM whether or not they have developed func-
tional abnormalities has not been previously made. It is unclear
from our studies whether this expansion occurs in a particular
portion of the cortical peritubular interstitium. It is also unclear
which elements making up the normal interstitium are in-
creased. Possibilities include fibroblast-like cells, lipid-laden
interstitial cells, macrophages and other nonresident cells,
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perivascular cells, fibnilar extracellular matrix, ground sub-
stance (proteoglycans, glycoproteins), interstitial fluid, and
lymphatic or peritubular capillary spaces [23]. Methods for
dissection of these structural variables using morphometry or
other means are not yet well developed. However, based on
subjective and semiquantitative immunofluorescent observa-
tions and electron microscopic analyses, it is our impression
that there is not a disproportionate increase in fibrillar extracel-
lular matrix material or matrix proteins in normal interstitial
areas in IDDM patients (unpublished observations).
Pinter Ct al have shown that the extravascular albumin pool is
expanded in the diabetic rat kidney, and that lymphatic flow is
increased as well [24, 25]. Interstitial expansion could, in part,
be the result of increased flow of lymph through the renal
cortex. Thus, both fibrosis and edema may play a role in
interstitial expansion in IDDM with their relative contributions
varying through the course of diabetic kidney disease. Intersti-
tial expansion in different locations or at different times during
the natural history of diabetic nephropathy may reflect different
processes. For example, increased Vv1 might primarily
represent expansion of non-matrix components of the intersti-
tium whereas interstitial expansion in abnormal areas may
reflect progression towards scarring. Study of the fine structural
and immunohistochemical composition of the renal interstitium
in IDDM is necessary to further delineate the nature of inter-
stitial expansion in diabetes.
Interstitial edema may contribute to the development of
nephropathy as discussed by Pinter and Atkins [26]. If plasma
protein leakage from peritubular capillaries exceeds lymphatic
drainage, hydrostatic pressure in the kidney will increase. This
pressure will be transmitted to the tubules and, eventually, to
the glomerulus. It is also possible that this increased pressure
may contribute to tubular atrophy [26].
The interrelationship of the lesions of interstitial expansion,
global glomerular sclerosis, and tubular atrophy remain to be
fully described. Our previous work has indicated that the
lesions of arteriolar hyalinosis, in their earlier stages, are not
associated with increased %GS [6]. Only when arteriolar hya-
linosis is far advanced does %GS increase. This suggests that
global glomerular sclerosis in diabetic nephropathy is at least in
part secondary to advanced arteriolar damage [6]. The coinci-
dent increase in interstitial volume may be secondary to this
glomerulosclerotic process. Advanced mesangial expansion ul-
timately leads to glomerular capillary closure, with, presum-
ably, the ultimate ischeniic demise of the glomerulus [1]. In
both instances marked changes of tubular ischemia and atrophy
would be expected and secondary responses to this nephron
injury, including inflammation and fibrosis, would occur.
It is also possible that tubulointerstitial injury could have a
more primary role. Jones et al found that the timing of extra-
cellular matrix accumulation in the interstitium and in the
glomeruli of rats with aminonucleoside of puromycin nephrosis
was sufficiently discrepant so as to hypothesize separate patho-
genic mechanisms [27]. Interstitial fibrosis may directly cause
tubular ischemic atrophy resulting in a nonfunctioning nephron
unit. Marcussen have studied this phenomenon in IDDM pa-
tients [28]. IDDM dialysis patients had increased numbers of
open glomeruli attached to atrophic tubules and increased
numbers of "atubular glomeruli" when compared with nondi-
abetic controls. While atubular glomeruli were not increased in
predialysis IDDM patients with proteinuria, the percent of
glomeruli with little or no sclerosis attached to atrophic tubules
was elevated [28]. Tubular atrophy may thus occur in the
absence of significant glomerulosclerosis in IDDM, resulting in
or representing dysfunctional or, in the case of atubular glomer-
uli, nonfunctional nephron units. Thus, the interstitial expan-
sion in abnormal cortical areas may theoretically both result
from and cause nephron loss. The elucidation of these possibil-
ities will require detailed longitudinal studies and the applica-
tion of more sophisticated structural analyses than performed
here.
It seems likely that mesangial expansion, arteriolar hyalino-
sis, and interstitial expansion represent more than one patho-
logical mechanism ultimately leading to renal dysfunction and
to glomerular sclerosis. However, renal dysfunction in diabetic
nephropathy can occur in the absence of increased %GS,
suggesting that mesangial and interstitial expansion alone, if far
advanced, can result in overt nephropathy. We have previously
suggested that increased Vvmes,&om may be causally associated
with a loss of ifitration surface in open glomeruli [4]. While we
did not demonstrate significant differences between patient
groups in this study for filtration surface per glomerulus, a trend
toward these differences was apparent. This difference from our
other work may be the result of differences in patient popula-
tions, since the current study included a lower proportion of
patients with overt nephropathy than our earlier work. Intersti-
tial expansion may result from global sclerosis but increased
may also, as suggested above, cause nephron alterations
and renal dysfunction. It is also possible that renal dysfunction
results directly from interstitial changes through changes in
tubuloglomerular feedback, or through altered post-glomerular
capillary structure and function [26]. However, in hydrone-
phrotic human kidneys the relative volume of peritubular
capillaries was not reduced unless the Vv1fl,T exceeded 40%, a
value reached by only one of our patients [29]. The distance
between peritubular capillaries and tubular basement mem-
branes was increased in the hydronephrotic kidneys and this
could have functional implications [29]. Such studies have not
yet been performed in diabetes.
In summary, mesangial expansion, arteriolar hyalinosis, glo-
bal glomerular sclerosis, and interstitial expansion are all inter-
related lesions in diabetic nephropathy, but may develop at
different rates in individual patients. Although patients with
clinical diabetic nephropathy tend to have all of these abnor-
malities, there are interesting exceptions. We have not encoun-
tered patients with overt nephropathy who do not have marked
mesangial and interstitial expansion. Patients with the other
lesions of diabetic nephropathy may develop renal dysfunction
with lesser abnormalities in the mesangium.
Finally, it should be mentioned that the often-claimed supe-
riority of measures of interstitial change over glomerular
changes as correlates of renal function was not confirmed by
our work. This claim was made in studies in which the intersti-
tium was quantitated using stereologic methods but glomerular
structure was estimated using subjective semiquantitative esti-
mates [7, 30—32]. Both were carefully measured in the current
study, and both correlated equally well with GFR and UAE.
Further studies, especially in patients with diseases producing
interstitial expansion in the absence of advanced glomerular
disease, are necessary for fuller elucidation of the role of
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interstitial changes in the genesis and progression of renal
dysfunction.
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